(firstQuint)Evaluation of the Effects of Simvastatin 40mg.

 This is an open-label, prospective study to investigate lipid-lowering efficacy and sympathetic response of normotensive hypercholesterolemia patients after receiving simvastatin 40 mg once daily for 3 months.

 The total duration of the study will be approximately 13 weeks, comprising of a 1-week (or 4 weeks?) screening period and a 12-week active treatment period.

 20 hypercholesterolemia patients with normal blood pressure will be enrolled into treatment group.

.

 Evaluation of the Effects of Simvastatin 40mg@highlight

To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia.

